Affiliation:
1. Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
2. Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University; Pirogov Russian National Research Medical University
Abstract
Proximal spinal muscular atrophy 5q is an autosomal recessive neuromuscular disease. This disorder is characterized by progressive symptoms of flaccid paralysis and muscular atrophy due to degeneration of α-motor neurons in the anterior horns of the spinal cord. The disease is caused by the lack of a fully functional SMN protein due to homozygous deletion of exon 7 in the SMN1 gene. For a long time, spinal muscular atrophy was the leading genetic cause of infant mortality. With the introduction of modern pathogenetic treatment methods that modify the disease, the duration and quality of life of patients increases, and a “blurring of boundaries” between types of spinal muscular atrophy and the formation of new phenotypes happens. In this regard, approaches to patient management, including approaches to the assessment and correction of respiratory disorders, are changing. The review of the available medical literature was conducted. The clinical studies on spinal muscular atrophy in the natural course of the disease and with the use of pathogenetic drugs were analyzed, as well as the data on the state of the respiratory system of the patients.
Publisher
The National Academy of Pediatric Science and Innovation
Reference32 articles.
1. Anisimova I.V., Artemyeva S.B., Belousova E.D., Vlodavets D.V., Volsky G.B., Germanenko O.Yu. et al. Proximal spinal muscular atrophy 5q. Guidelines, 2023; 118. (in Russ.)
2. Kolb S.J., Coffey C.S., Yankey J.W., Krosschell K., Arnold W.D., Rutkove S.B. et al. NeuroNEXT Clinical Trial Network on behalf of the NN101 SMA Biomarker Investigators. Natural history of infantile-onset spinal muscular atrophy. Ann Neurol 2017; 82(6): 883–891. DOI: 10.1002/ana.25101
3. Cances C., Vlodavets D., Comi G.P., Masson R., Mazurkiewicz-Bełdzińska M., Saito K. et al.; ANCHOVY Working Group. Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study. Orphanet J Rare Dis 2022; 17(1): 300. DOI: 10.1186/s13023–022–02455-x
4. Fauroux B., Khirani S., Griffon L., Teng T., Lanzeray A., Amaddeo A. Non-invasive Ventilation in Children With Neuromuscular Disease. Front Pediatr 2020; 8: 482. DOI: 10.3389/fped.2020.00482.
5. Babak S.L. Noninvasive ventilation. A practical guide to respiratory medicine. M.: TRIMM Group of Companies, 2020; 335. (in Russ.)